The government is on track to approve a new antibiotic to treat a pneumonia-like disease in cattle, despite warnings from health groups and a majority of the agency's own expert advisers that the decision will be dangerous for people. Full Story »
Posted by Leo Romero
To:
Separate email addresses with commas.
25 recipients max.
Note:
Sad truths about FDA. Nothing about Posts complicity in GOP election, or their lack of real effort to change the system, which is undermining all regulator aspects of Bush government.
This topic is extremely important, as we must be ever mindful of the FDA officials' inability to resist temptations placed upon them by the pharmaceutical industry. Over 80% of the studies done on new drug safety are privately funded, placing extreme pressure on the FDA to produce "good" results--the results desired by the funder. The questions about the potential risks of these new drugs must be answered convincingly, and must show a high degree of safety, before the healthcare ... More »
Extensivel sourced, this story points to a troubling new regulatory policy favoring big pharma over health concerns
Because antibiotics are not big money makers, big pharma doesn't spend much time or money developing them. Unfortunately, germs have no such limitations. So, while our treatment options dwindle, the number of antibiotic-resistant bugs continues to grow. This will only make it worse, as this story makes clear. Two important points--one in the opening of the story--is that the FDA is making this decision because of corporate pressure and against the advice of experts we pay, and ... More »
With other drugs available to treat the same illnesses in cattle, why put humans at risk? The promise to stop using it in cattle the moment it results in increase risk to humans is disingenuous and egotistical. This article underscores the need to refund our consumer protection agencies.
Without using the word "corruption," this story gives one more example of the inadequacy of pinning the responsibility for protecting the public on regulatory bodies such as the FDA. The problem with the FDA is that it is entirely in the pockets of the businesses it is supposed to regulate. Too many FDA staffers eventually go to work for those same organizations, and given that the FDA commissioners are all political appointees, they are only as public-spirited, committed to food and ... More »
Retrieving Comments
